[IOICORP] QoQ TTM Result on 31-Dec-2002 [#2]

Stock
[IOICORP] IOI CORPORATION BHD
Announcement Date
18-Feb-2003
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2003
Quarter
31-Dec-2002 [#2]
Profit Trend
QoQ- 16.95%
YoY- 50.27%
Quarter Report
Latest QR
Upcoming QR
IOICORP's Result
IOICORP's Financial Summary
View:
Show?
TTM Result
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Revenue 4,475,899 3,907,871 3,575,886 3,102,974 2,751,938 2,410,500 1,944,581 74.24%
PBT 871,023 812,626 754,751 768,565 677,146 569,310 479,807 48.75%
Tax -339,052 -280,574 -263,055 -259,573 -237,577 -222,809 -195,946 44.08%
NP 531,971 532,052 491,696 508,992 439,569 346,501 283,861 51.94%
-
NP to SH 531,971 502,052 461,696 478,992 409,569 346,501 283,861 51.94%
-
Tax Rate 38.93% 34.53% 34.85% 33.77% 35.09% 39.14% 40.84% -
Total Cost 3,943,928 3,375,819 3,084,190 2,593,982 2,312,369 2,063,999 1,660,720 77.90%
-
Net Worth 3,186,329 3,103,138 2,742,453 2,588,287 2,897,710 2,817,557 2,547,482 16.07%
Dividend
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Div 195,591 195,591 170,951 170,951 130,008 130,008 113,500 43.68%
Div Payout % 36.77% 38.96% 37.03% 35.69% 31.74% 37.52% 39.98% -
Equity
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Net Worth 3,186,329 3,103,138 2,742,453 2,588,287 2,897,710 2,817,557 2,547,482 16.07%
NOSH 1,044,698 1,041,321 929,645 914,589 886,150 883,246 849,160 14.80%
Ratio Analysis
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
NP Margin 11.89% 13.61% 13.75% 16.40% 15.97% 14.37% 14.60% -
ROE 16.70% 16.18% 16.84% 18.51% 14.13% 12.30% 11.14% -
Per Share
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
RPS 428.44 375.28 384.65 339.28 310.55 272.91 229.00 51.77%
EPS 50.92 48.21 49.66 52.37 46.22 39.23 33.43 32.34%
DPS 18.72 18.78 18.39 18.69 14.67 14.72 13.50 24.32%
NAPS 3.05 2.98 2.95 2.83 3.27 3.19 3.00 1.10%
Adjusted Per Share Value based on latest NOSH - 914,589
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
RPS 72.17 63.01 57.66 50.04 44.37 38.87 31.36 74.22%
EPS 8.58 8.10 7.44 7.72 6.60 5.59 4.58 51.90%
DPS 3.15 3.15 2.76 2.76 2.10 2.10 1.83 43.58%
NAPS 0.5138 0.5004 0.4422 0.4174 0.4673 0.4543 0.4108 16.06%
Price Multiplier on Financial Quarter End Date
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Date 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 28/06/02 29/03/02 -
Price 1.23 1.14 0.98 1.11 1.15 1.22 1.10 -
P/RPS 0.29 0.30 0.25 0.33 0.37 0.45 0.48 -28.51%
P/EPS 2.42 2.36 1.97 2.12 2.49 3.11 3.29 -18.49%
EY 41.40 42.29 50.68 47.18 40.19 32.16 30.39 22.86%
DY 15.22 16.48 18.76 16.84 12.76 12.07 12.27 15.43%
P/NAPS 0.40 0.38 0.33 0.39 0.35 0.38 0.37 5.32%
Price Multiplier on Announcement Date
30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 CAGR
Date 17/11/03 15/08/03 16/05/03 18/02/03 15/11/02 12/08/02 14/05/02 -
Price 1.49 1.18 1.01 1.18 1.14 1.21 1.25 -
P/RPS 0.35 0.31 0.26 0.35 0.37 0.44 0.55 -25.99%
P/EPS 2.93 2.45 2.03 2.25 2.47 3.08 3.74 -15.00%
EY 34.18 40.86 49.17 44.38 40.54 32.42 26.74 17.76%
DY 12.57 15.92 18.21 15.84 12.87 12.16 10.80 10.63%
P/NAPS 0.49 0.40 0.34 0.42 0.35 0.38 0.42 10.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment